Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS often have metabolic issues like insulin resistance and a higher risk of diabetes and abnormal lipid levels.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

More research is needed on the health effects of hormone therapy for transgender and nonbinary people.

Some skin conditions may increase the risk of heart disease, but are not yet included in cardiovascular prevention guidelines.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

Medications for PCOS don't seem to raise heart disease risk.

The conclusion is that managing cholesterol is important for women, especially during pregnancy, breastfeeding, and with PCOS, and involves regular screening and careful treatment choices.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

Linagliptin slows down premature aging in certain mice.

While PCOS might increase the risk of heart disease, there's not strong evidence to prove it causes earlier heart problems.

Metabolic syndrome is more common in people with early-onset androgenic alopecia.

Men with male pattern baldness have a higher risk of dying from prostate cancer.

Testosterone is linked to cardiovascular risk factors and stroke, but its exact role is unclear.

Men with common hair loss (AGA) are more likely to have metabolic syndrome, which increases heart disease risk. Early screening could help prevent heart disease. More research is needed to understand this relationship better.

Young Indian women with PCOS have a higher risk of heart disease, not linked to thyroid function but to higher levels of certain fats and homocysteine.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

K_ATP channel gene mutations are linked to heart diseases, but more research is needed to understand the connection and treatment potential.

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.

Vasodilators may worsen abdominal aortic aneurysm.

Birth control pills increase the risk of blood clots, especially within the first year and with certain types.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Sex hormone treatments can increase muscle mass in older adults but have inconsistent effects on muscle function and may carry cardiovascular risks.

The Rotterdam Study updated findings on elderly health, focusing on heart disease, genetics, lifestyle effects, and disease understanding.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

People with cutaneous Lichen Planus are more likely to have Metabolic Syndrome and related conditions like high cholesterol, diabetes, and high blood pressure.

Androgens and a high-fat diet may increase the risk of severe COVID-19 in women with PCOS by upregulating certain proteins in the heart and kidneys.

Traditional Chinese Medicine and acupuncture may improve Polycystic Ovarian Syndrome symptoms and reduce costs, but more research is needed.